PEGASUS: A Phase 3 study to evaluate the efficacy and safety of APL-2 in patients with PNH
Have you been diagnosed with Paroxysmal Nocturnal Hemoglobinuria (PNH) and are currently taking eculizumab for your condition?
Interested in learning more about a clinical trial for PNH?
A Phase III trial for patients with PNH is enrolling now! Click on the PEGASUS Study Website link below to learn more. The trial is being conducted at multiple sites in Alberta, Ontario, and Quebec.
MEDALIST: A study of luspatercept (ACE-536) to treat anemia due to very low, low, or intermediate risk MDS
Do you have MDS and are interested in participating in a clinical trial?
Please visit the MEDALIST trial page on ClinicalTrials.gov to learn more. If you feel that you qualify, please print the clinical trial information and discuss with your oncologist/hematologist.
Presently the trial is being conducted at: Juravinski Cancer Centre at Hamilton Health Sciences Centre, Princess Margaret Hospital and Odette Cancer Centre at Sunnybrook Hospital.
Search for clinical trials
AAMAC works with partners to provide ways to participate in clinical trials near you. There are several ways to find clinical trials, including a quick search function provided by Antidote.
AAMAC does not recommend, endorse, or make any representation about the efficacy, appropriateness or suitability of any clinical trial listed on this website.
Pharmaceutical company-sponsored content is highlighted only to give additional information about the trial. All trials are listed on https://clinicaltrials.gov/. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a clinical trial, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.